stars 1 stars 2 stars 3

Genome editing is transforming the way biological science is done and accelerating medical breakthroughs. CRISPR technology has reduced the barrier to creating predictable changes to DNA, encouraging scientific investigators and entrepreneurs to adopt and use the technology. However, robust and rigorous computational tools are critical for the correct analysis, interpretation and verification of biological results. We build precision algorithms for analyzing genome editing experimental data, and provide customized computational support to address critical questions in the processing of next-generation sequencing data. Please get in touch with us to get more information or to start a collaboration.

Edilytics Questions

Cole Lyman is the CEO of Edilytics.

3 people are employed at Edilytics.

Edilytics is based in Cambridge, Massachusetts.

Top Edilytics Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users